Spruce Biosciences, Inc. (SPRB)
NASDAQ: SPRB · Real-Time Price · USD
62.11
+6.24 (11.17%)
At close: Mar 9, 2026, 4:00 PM EDT
62.07
-0.04 (-0.06%)
After-hours: Mar 9, 2026, 7:02 PM EDT
Spruce Biosciences Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Net Income | -38.97 | -53.04 | -47.92 | -46.18 | -42.29 | |
| Depreciation & Amortization | 0.02 | 0.05 | 0.07 | 0.07 | 0.07 | |
| Loss (Gain) From Sale of Assets | - | 0 | 0 | 0.04 | - | |
| Loss (Gain) From Sale of Investments | - | - | -0.64 | 0.02 | 0.12 | |
| Stock-Based Compensation | 2.57 | 5.35 | 4.62 | 3.63 | 3.96 | |
| Other Operating Activities | 3.77 | 0.25 | 0.23 | -0.4 | 0.31 | |
| Change in Accounts Payable | -0.35 | -2.04 | 1.91 | -1.4 | -0.81 | |
| Change in Unearned Revenue | - | -4.91 | 4.91 | - | - | |
| Change in Other Net Operating Assets | -0.37 | -1.62 | 3.54 | 2.53 | 2.76 | |
| Operating Cash Flow | -33.33 | -55.96 | -33.28 | -41.68 | -35.88 | |
| Capital Expenditures | - | - | -0.01 | -0.01 | -0.09 | |
| Investment in Securities | - | - | 55.78 | 23.7 | -79.08 | |
| Investing Cash Flow | - | - | 55.78 | 23.69 | -79.17 | |
| Long-Term Debt Issued | - | - | - | - | 5 | |
| Long-Term Debt Repaid | -2.06 | -1.62 | -1.62 | - | -4.77 | |
| Net Debt Issued (Repaid) | -2.06 | -1.62 | -1.62 | - | 0.23 | |
| Issuance of Common Stock | 50.07 | 0.25 | 53.79 | 0.08 | 0.46 | |
| Repurchase of Common Stock | -0.83 | -0.25 | -0.31 | -0.04 | - | |
| Other Financing Activities | -3.7 | - | -2.72 | -0.28 | -0.05 | |
| Financing Cash Flow | 43.48 | -1.62 | 49.14 | -0.24 | 0.64 | |
| Net Cash Flow | 10.15 | -57.59 | 71.64 | -18.23 | -114.4 | |
| Free Cash Flow | -33.33 | -55.96 | -33.28 | -41.69 | -35.97 | |
| Free Cash Flow Margin | - | -1139.56% | -329.88% | - | - | |
| Free Cash Flow Per Share | -43.47 | -101.72 | -64.82 | -132.90 | -115.48 | |
| Cash Interest Paid | 0.07 | 0.23 | 0.37 | 0.27 | 0.21 | |
| Levered Free Cash Flow | -23.86 | -38.75 | -17.52 | -25.55 | -20.7 | |
| Unlevered Free Cash Flow | -23.81 | -38.56 | -17.22 | -25.28 | -20.49 | |
| Change in Working Capital | -0.72 | -8.57 | 10.36 | 1.13 | 1.96 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.